Amerant Bancorp Appoints Technology and Financial Industry Veterans to Board

By Hao Liu • Tuesday, June 24 10:14 • Permanent Link

Amerant Bancorp Inc. (NYSE: AMTB) and its subsidiary, Amerant Bank, N.A., have recently appointed two new board members, Patricia “Patty” Morrison and Jack Kopnisky. Morrison, a former chief information officer of Cardinal Health, brings extensive technology expertise, having held leadership roles at Motorola, Office Depot, PepsiCo, and GE. She currently serves on the board of directors of Baxter International Inc. (NYSE: BAX). Kopnisky, with over 40 years of financial services industry experience, was most recently the executive chairman of Webster Financial Corporation (NYSE: WBS) and Webster Bank.

These appointments reflect Amerant's commitment to strategic growth and strengthening its board of directors and executive management. The addition of Morrison and Kopnisky follows the earlier appointment of senior leaders Lisa Lutoff-Perlo and Odilon Almeida Júnior to the board of directors in January 2025.

Amerant Bancorp Inc. is a bank holding company headquartered in Coral Gables, Florida, operating through its subsidiaries Amerant Bank, N.A., Amerant Investments, Inc., and Amerant Mortgage, LLC. The company provides deposit, credit, and wealth management services to individuals and businesses. The bank operates 20 banking centers, with 19 in South Florida and 1 in Tampa, FL. Following these announcements, the company's shares moved 3.71%, and are now trading at a price of $17.31. Check out the company's full 8-K submission here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.